- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 26.02. | AI-enabled, human-interpreted: the future of pharma marketing insights is precision intelligence | ||
| 26.02. | It's time for an end to pharma exceptionalism | ||
| 25.02. | The race to explore and harness GenAI in healthcare | ||
| 25.02. | The 'jagged frontier', straight talk and why humans still matter | ||
| 25.02. | GSK to acquire 35Pharma for $950m including a potential drug for pulmonary hypertension | ||
| 24.02. | Novo Nordisk to lower list price, or wholesale acquisition cost, for Wegovy and Ozempic | ||
| 24.02. | Incyte Biosciences UK announces NICE approval for Opzelura for vitiligo | ||
| 23.02. | Copenhagen Airports A/S, SAS Cargo and World Courier to host FlyPharma 2026 | ||
| 23.02. | Gilead to acquire Arcellx in deal worth $7.8bn | ||
| 20.02. | PureTech's deupirfenidone gets FDA and EC Orphan Drug Designations for idiopathic pulmonary fibrosis | ||
| 20.02. | CGT Catapult establishes Technology Advisory Board led by chair Phil Vanek | ||
| 19.02. | Diabeloop's DBLG2 receives FDA and CE clearance for automated insulin delivery without meal input | ||
| 19.02. | Human Continuum appoints Omar Khalid Sial as Chief Scientific Officer | ||
| 18.02. | British Chambers of Commerce partners with Singapore to scale up UK imports | ||
| 18.02. | The PM Society launches Pharmony to support more effective pharma-agency collaboration | ||
| 18.02. | Communication breakdown | ||
| 17.02. | UCB's Kygevi receives positive CHMP opinion for thymidine kinase 2 deficiency | ||
| 17.02. | THX Pharma appoints Julien Veys as Deputy CEO | ||
| 17.02. | Medicine shortages strike again - can radio-frequency identification technology help? | ||
| 16.02. | Pandemic readiness is now a financial risk test - and the UK must treat it that way | ||
| 16.02. | Study shows infants given RSV vaccination benefit beyond first RSV season | ||
| 12.02. | Sanofi announces positive results for venglustat in type 3 Gaucher disease | ||
| 12.02. | Putting AI to work for pharma marketing leaders of the future | ||
| 11.02. | Bayer launches 'Anything but Normal' campaign highlighting women's health issues | ||
| 11.02. | Designing healthcare AI that works for every patient |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.